Fig. 3From: Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patientsROC curve analysis for ability of serum sCD14 and sTLR4 for discrimination between patients with non severe and severe COVID-19 infection (AUC for sCD14 = 0.665 and for sTLR4 = 0.655)Back to article page